Literature DB >> 14515669

[Gastropathy caused by non-steroidal anti-inflammatory agents and its association with Helicobacter pylori].

Heriberto Rodríguez-Hernández1, Janett S Jacobo-Karam, Joel O Jáquez-Quintana, Hilda G Avila-Romero, Liliana Galván-Román, Sandra C Lara-Miranda, Luis F Sánchez-Anguiano.   

Abstract

BACKGROUND: Upper gastrointestinal bleeding that is related with older patients and NSAIDs use. The frequency of peptic ulcer bleeding varies of 15% to 30% of cases.
OBJECTIVE: To determine the gastropathy features of patients who receive nonsteroidal anti-inflammatory drug, and its relation with Helicobacter pylori (Hp).
METHODS: Men and women with GU or DU with or without haemorrhage, were included into two groups, NSAIDs users and non users. We determined the incidence rate of peptic ulcer and the frequencies of risk factors as tobacco use, previous peptic ulcer or haemorrhage, concomitant disease presence and its association with Hp infection.
RESULTS: We included 434 (67.5%) patients that used NSAIDs and 209 (32.5%) non NSAIDs users control subjects. The average was 62.5 +/- 17.2 years and 49.5 +/- 19.4 years respectively. The annual incidence rate of peptic ulcer in NSAIDs users was 17.5%. Gastrointestinal bleeding was more frequent in NSAIDs users and its relations with Hp infection (23.5%) was smaller than patients without NSAIDs user (47.7%) (OR 0.39 p = 0.0000).
CONCLUSIONS: The GU was highly frequent in the older people who using NSAIDs. The Hp infection shows lower incidence of gastrointestinal bleeding NSAIDs users.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515669

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  1 in total

1.  The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease.

Authors:  Juan Carlos Zapata-Colindres; Sergio Zepeda-Gómez; Aldo Montaño-Loza; Edgar Vázquez-Ballesteros; José de Jesús Villalobos; Francisco Valdovinos-Andraca
Journal:  Can J Gastroenterol       Date:  2006-04       Impact factor: 3.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.